LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹37 Cr | ₹27 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹37 Cr |
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹43 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 39.26 | |
| Mar2025 | ₹27 Cr | -14.69 | |
| Mar2024 | ₹32 Cr | -7.30 | |
| Mar2023 | ₹34 Cr | -20.24 | |
| Mar2022 | ₹43 Cr | - | |
Compare Contingent Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹229.0 Cr | 2.1% | -12.2% | -45.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 2.1% |
-12.2% |
-45.9% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses